<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04074824</url>
  </required_header>
  <id_info>
    <org_study_id>2017.493</org_study_id>
    <nct_id>NCT04074824</nct_id>
  </id_info>
  <brief_title>A Genome-Wide Association Study for Neonatal Diseases</brief_title>
  <official_title>A Genome-Wide Association Study on Chinese Preterm Neonates and Identification of Functional Variants for Susceptibility to Necrotising Enterocolitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study to identify genetic risks for neonatal diseases, necrotizing
      enterocolitis (NEC) using genome-wide association study (GWAS) and enterotype investigation.
      We hypothesize that specific genetic factors and microbiome could predispose preterm neonates
      for the development of NEC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      NEC is the most frequently encountered surgical emergencies and a life-threatening disease
      that predominantly affects preterm neonates. The incidence is estimated to be 7-10% in ver
      low birth weight (VLBW) neonates (Lin and Stoll, 2006; Neu and Walker, 2011). However, a
      significant proportion of affected neonates (20-30%) develops severe progressive disease with
      intestinal necrosis and complications resulting in gut perforation and peritonitis which
      require urgent surgical intervention (surgical cases) (Sharma et al., 2006). The mortality
      rate of surgical cases is high (25-50%), and may increase to 100% in patients with
      pan-necrosis of the bowel. Those neonates who survived often suffer severe morbidity,
      including short bowel syndrome, parenteral nutrition-associated cholestasis, poor physical
      growth and neurodevelopmental impairment (Neu and Walker, 2011; Salhab et al., 2004).
      However, the etiology and pathophysiology of NEC remain incompletely understood. The current
      knowledge has directed towards multiple predisposing factors which include prematurity,
      immature gut mucosa and host defense immunity, formula milk feeding and altered microbial
      colonization in the gut resulting in excessive inflammatory response, leading to irreversible
      intestinal cell death and gut necrosis (Neu and Walker, 2011; Chan et al., 2013). To date, no
      genetic risk markers or biomarkers are available for reliable prediction of neonates who are
      at high risk of developing NEC. Besides host genetic factors, gut bacteria have been reported
      to predispose neonates to disease risk (Mai et. al., 2011; Neu and Pammi, 2018).

      In this study, we shall conduct a GWAS on Chinese preterm neonates for identification of
      genetic risks for NEC and determine gut microbiome structure (enterotype) of NEC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>NEC</measure>
    <time_frame>First year</time_frame>
    <description>Neonatal Disease</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">310</enrollment>
  <condition>Neonatal Disease</condition>
  <condition>Necrotizing Enterocolitis</condition>
  <arm_group>
    <arm_group_label>Non-NEC</arm_group_label>
    <description>Those without NEC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NEC</arm_group_label>
    <description>Those with NEC</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Chinese infants
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Chinese infants admitted in the neonatal unit (NNU)

        Exclusion Criteria:

        Refuse consent for study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kathy Chan, Ph. D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>CUHK</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathy Chan, Ph. D.</last_name>
    <phone>852 3505 2858</phone>
    <email>kathyyychan@cuhk.edu.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Chan, Ph. D.</last_name>
      <phone>852 3505 2858</phone>
      <email>kathyyychan@cuhk.edu.hk</email>
    </contact>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <reference>
    <citation>Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. 2006 Oct 7;368(9543):1271-83. Review.</citation>
    <PMID>17027734</PMID>
  </reference>
  <reference>
    <citation>Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011 Jan 20;364(3):255-64. doi: 10.1056/NEJMra1005408. Review.</citation>
    <PMID>21247316</PMID>
  </reference>
  <reference>
    <citation>Sharma R, Hudak ML, Tepas JJ 3rd, Wludyka PS, Marvin WJ, Bradshaw JA, Pieper P. Impact of gestational age on the clinical presentation and surgical outcome of necrotizing enterocolitis. J Perinatol. 2006 Jun;26(6):342-7.</citation>
    <PMID>16724075</PMID>
  </reference>
  <reference>
    <citation>Salhab WA, Perlman JM, Silver L, Sue Broyles R. Necrotizing enterocolitis and neurodevelopmental outcome in extremely low birth weight infants &lt;1000 g. J Perinatol. 2004 Sep;24(9):534-40.</citation>
    <PMID>15254558</PMID>
  </reference>
  <reference>
    <citation>Chan KY, Leung KT, Tam YH, Lam HS, Cheung HM, Ma TP, Lee KH, To KF, Li K, Ng PC. Genome-wide expression profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in human intestinal tissues: dysregulation of functional pathways. Ann Surg. 2014 Dec;260(6):1128-37. doi: 10.1097/SLA.0000000000000374.</citation>
    <PMID>24368664</PMID>
  </reference>
  <reference>
    <citation>Mai V, Young CM, Ukhanova M, Wang X, Sun Y, Casella G, Theriaque D, Li N, Sharma R, Hudak M, Neu J. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One. 2011;6(6):e20647. doi: 10.1371/journal.pone.0020647. Epub 2011 Jun 6.</citation>
    <PMID>21674011</PMID>
  </reference>
  <reference>
    <citation>Neu J, Pammi M. Necrotizing enterocolitis: The intestinal microbiome, metabolome and inflammatory mediators. Semin Fetal Neonatal Med. 2018 Dec;23(6):400-405. doi: 10.1016/j.siny.2018.08.001. Epub 2018 Aug 17. Review.</citation>
    <PMID>30172660</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 29, 2019</study_first_submitted>
  <study_first_submitted_qc>August 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 30, 2019</study_first_posted>
  <last_update_submitted>August 29, 2019</last_update_submitted>
  <last_update_submitted_qc>August 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Kathy Chan</investigator_full_name>
    <investigator_title>Scientific Officer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

